FDA recall, , Moderate risk
American National Red Cross Blood Services Apheresis Platelets
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were not tested for pH and were distributed.
Recall ended Aug 28, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
American National Red Cross Blood Services SW Region began a recall of Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced on March 19, 2026, because the product was not tested for pH and was distributed. The FDA added the recall to its Enforcement Report on August 28, 2026, and classified it the same day. The recall was listed in the FDA's weekly enforcement report on September 9, 2026, and involved Texas.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
Recall details
- Company began the recall
- Sold in
- Company
- American National Red Cross Blood Services SW Region
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99397
- Recall number
- B-0187-2026
All recalls from American National Red Cross Blood Services SW Region
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
